Survival Outcomes With Trastuzumab Deruxtecan in HER2-positive Vs. HER2-low Breast Cancer Patients With Brain Metastases: A Real-world Cohort Study

Vivek Podder, Zouina Sarfraz, Tulika Ranjan, Andrea McCracken, Charlie Hurmiz, Lydia Hodgson, Arun Maharaj, Reshma Mahtani & Manmeet S. Ahluwalia